Titan Biotech Limited

₹347.65As of Sun 8 Nov 2026, 12:00 UTC
BSE:524717Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 46.95%
Div yield 0.12%
ROE 20.94%
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.54)
PE TTM 61.34
TSR TTM 106.36%
Mkt cap ₹17.96B
ROIC 16.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹359
3.24%
(97.26%)
Hold 2|12|1|11|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
6.43
6.80
6.69
6.82
15.45%
9.13%
8.52%
7.07%
Revenue₹M
793.6
837.8
880.3
915.3
8.08%
15.70%
17.10%
19.11%
Peers (US$191.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.468
0.082
0.078
EBIT/Intx
1.695
0.247
0.229
Own earn%
15.24
(60.46)
(58.78)
Sh yield%
44.08
1.77
2.47
Owners
Insiders/Inst%
10.51
25.72
Short interest%
5.90
SBC / revenue%
3.12
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
14–20
$1 testx
—
Incr. ROIC%
3